| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
New Section: The Schwartz Center Rounds |
Hematology-Oncology Department, Massachusetts General Hospital, Boston, Massachusetts, USA
Correspondence: Bruce A. Chabner M.D., Massachusetts General Hospital Cancer Center, Cox Building, Room 640, 100 Blossom Street, Boston, Massachusetts 02114-2617, USA. Telephone: 617-724-3200; Fax: 617-724-3166; e-mail: chabner.bruce{at}mgh.harvard.edu
Shortly before his death in 1995, Kenneth B. Schwartz, a
cancer patient at Massachusetts General Hospital, founded The Kenneth
B. Schwartz Center to be housed at Massachusetts General Hospital
(MGH). He created this center to advance the hopes, goals, and ideas
expressed in his article, "A Patient's Story,"
published in the July 16, 1995 issue of the Boston Globe
Magazine. The Schwartz Center is a non-profit organization
dedicated to strengthening the relationship between patients and
caregivers and to supporting and advancing "compassionate health
care delivery in which caregivers, patients and their families relate
meaningfully to one another in a way that provides hope to the
patient, support to caregivers and sustenance to the healing
process." One of the Center's major projects is the
sponsoring of the Schwartz Center Rounds, a monthly, multidisciplinary
forum in which caregivers discuss a specific cancer patient and the
important psychosocial issues faced by the patient, family and
caregivers. The forum allows caregivers to reflect on their
experiences with patients and to gain support and insight from fellow
staff members.
The following case discussion was addressed at the January 1998
Schwartz Center Rounds. In this article, the case will be presented,
followed by verbatim dialogue from the rounds and a subsequent
discussion of the relevant issues with emphasis on staff psychosocial
issues.
J.T. was a 43-year-old man who developed adenocarcinoma
of the lung and was treated at MGH. He died while participating in a
phase I trial, resulting in marked frustration and distress among his
caregivers. Staff questioned whether cancer patients entering phase I
trials and their families receive unbiased information about the
possible risks and benefits of the trial. They were also concerned
about whether or not patients and their families really
understand the physical and emotional risks of a
trial. Moreover, they addressed whether patients are presented with
alternatives to enrolling in a phase I trial, such as palliative
care. Despite all these concerns, caregivers are reconciled to the
belief that patients do value the opportunity to participate in phase
I trials, in that they can contribute hope and meaning to other
patients' struggles with cancer.
Related articles in The Oncologist:
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| THE ONCOLOGIST | STEM CELLS | CME | ALPHAMED PRESS JOURNALS |